Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart disease

Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart disease

<p><strong>Objective</strong> Incident type 2 diabetes is common among patients with recent acute coronary syndrome and is associated with an adverse prognosis. Some data suggest that cholesteryl ester transfer protein (CETP) inhibitors reduce incident type 2 diabetes. We compared...

Descrición completa

Detalles Bibliográficos
Main Authors:	Schwartz, GG, Leiter, LA, Ballantyne, CM, Preiss, D, Et al.
Formato:	Journal article
Idioma:	English
Publicado:	American Diabetes Association 2020

Títulos similares

Improved Synthesis and Crystal Structure of Dalcetrapib
por: Frank Richter, et al.
Publicado: (2012-10-01)

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
por: Goldberg AS, et al.
Publicado: (2012-09-01)

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
por: Mathieu R. Brodeur, et al.
Publicado: (2023-01-01)

Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys
por: Mathieu R. Brodeur, et al.
Publicado: (2017-07-01)

Inhibition of the 3CL Protease and SARS-CoV‑2 Replication by Dalcetrapib
por: Eric J Niesor, et al.
Publicado: (2021-06-01)

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
por: Xu, S, et al.
Publicado: (2019)

Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure
por: Preiss, D, et al.
Publicado: (2016)

Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials
por: Goldie, C, et al.
Publicado: (2016)

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
por: Kristensen, S, et al.
Publicado: (2016)

Glutamic acid decarboxylase antibodies are indicators of the course, but not of the onset, of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities Study
por: A. Vigo, et al.
Publicado: (2007-07-01)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
por: Stevens, R, et al.
Publicado: (2005)

Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors
por: Harold Bays, et al.
Publicado: (2007-11-01)

Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes.
por: White, J, et al.
Publicado: (2016)

Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery Disease.
por: Chul Soo Park, et al.
Publicado: (2015-01-01)

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): A randomised controlled trial
por: Preiss, D, et al.
Publicado: (2014)

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.
por: Preiss, D, et al.
Publicado: (2014)

Risk factors and characteristics of new-onset coronary heart disease in adults with physical disabilities: A retrospective cohort study
por: Jing Wu, et al.
Publicado: (2023-03-01)

Individual participant data meta-analysis of new-onset and worsening diabetes mellitus in large-scale randomized double-blind trials of statin therapy
por: Preiss, D, et al.
Publicado: (2022)

Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic
por: Maguy Chiha, et al.
Publicado: (2012-01-01)

Risk factors for new-onset heart failure with reduced or preserved ejection fraction in patients with ischemic heart disease: A cohort study
por: Senbeta Guteta Abdissa
Publicado: (2021-01-01)

Diabetes mellitus and risk of new‐onset and recurrent heart failure: a systematic review and meta‐analysis
por: Satoru Kodama, et al.
Publicado: (2020-10-01)

Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure
por: Reynaria Pitts, et al.
Publicado: (2017-01-01)

Changes in Lipoprotein Lipase in the Heart Following Diabetes Onset
por: Chae Syng Lee, et al.
Publicado: (2023-01-01)

Hypomagnesemia is associated with new-onset diabetes mellitus following heart transplantation
por: Yael Peled, et al.
Publicado: (2019-10-01)

Missense Variant rs28362680 in BTNL2 Reduces Risk of Coronary Heart Disease
por: Zhuo J, et al.
Publicado: (2022-05-01)

Risk factors for coronary heart disease in non-insulin dependent diabetic subjects
por: Turner, R, et al.
Publicado: (1996)

Risk of coronary heart disease in type 2 diabetes mellitus patients in Kelantan
por: Ghani, Nurul Akmar
Publicado: (2011)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
por: Holman, R, et al.
Publicado: (2001)

RISK FACTORS OF CORONARY HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
por: Elisabeth Sekaringtyas Medistya Putri, et al.
Publicado: (2022-01-01)

Long‐term gender disparities in new‐onset heart failure after acute coronary syndrome
por: Pierluigi Merella, et al.
Publicado: (2024-12-01)

Factors Associated With Coronary Artery Disease Testing Among Patients With New-Onset Heart Failure
por: Siamak Kohan, MD, et al.
Publicado: (2024-11-01)

The Degrees of Coronary Heart Disease and the Degrees of New-Onset Blepharitis: A Nationwide Cohort Study
por: Chia-Yi Lee, et al.
Publicado: (2024-06-01)

Hypercholesterolemia as a risk factor for coronary heart disease
por: Hadeel Al-daraji, et al.
Publicado: (2022-02-01)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: S. Heleen Binnenmars, et al.
Publicado: (2022-08-01)

Coronary Angiographic Findings in Diabetic Patients Versus non-Diabetics with Coronary Heart Disease
por: Akram Rasol Kadhim, et al.
Publicado: (2013-01-01)

Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
por: Rahimi, K, et al.
Publicado: (2017)

Genetic insights into statin-associated diabetes risk
por: Swerdlow, DI, et al.
Publicado: (2016)

Reducing social inequalities and the prevention of coronary heart disease.
por: Emberson, JR, et al.
Publicado: (2004)

Patients with insulin-dependent diabetes or coronary heart disease following rehabilitation express serum fractalkine levels similar to those in healthy control subjects
por: Lars Maegdefessel, et al.
Publicado: (2009-10-01)

Risk of new-onset diabetes associated with statin use
por: Robert D Beckett, et al.
Publicado: (2015-09-01)